实用放射学杂志
實用放射學雜誌
실용방사학잡지
JOURNAL OF PRACTICAL RADIOLOGY
2014年
6期
999-1002
,共4页
张伟%刘贺亮%刘卫迎%杨焱%李振武%印弘%彭锐%孙立军
張偉%劉賀亮%劉衛迎%楊焱%李振武%印弘%彭銳%孫立軍
장위%류하량%류위영%양염%리진무%인홍%팽예%손립군
经皮冷冻消融%冷冻外科%嗜铬细胞瘤%肾上腺瘤
經皮冷凍消融%冷凍外科%嗜鉻細胞瘤%腎上腺瘤
경피냉동소융%냉동외과%기락세포류%신상선류
percutaneous cryoablation%cryosurgery%pheochromocytoma%adrenal adenoma
目的:评价经皮 CT 导引氩氦冷冻消融术治疗肾上腺肿瘤的安全性及可行性。方法对17例肾上腺肿瘤患者实施经皮CT 导引氩氦冷冻消融术,其中3例因肿瘤较大,术后3月行第2次消融治疗;4例因血供丰富消融前行动脉栓塞。8例嗜铬细胞瘤患者术中行动脉连续测压。结果所有患者操作均获得成功,术中及术后无严重并发症。8例嗜铬细胞瘤患者冷冻治疗前后及复温过程中血压变化差异有统计学意义(P <0.05)。在随访3~24月中,消融区域 CT 扫描无增强和/或 FDG PET-CT 无摄取。结论经皮 CT 导引氩氦冷冻消融术治疗肾上腺肿瘤安全可靠,尤其可用于不适宜外科手术患者的治疗。
目的:評價經皮 CT 導引氬氦冷凍消融術治療腎上腺腫瘤的安全性及可行性。方法對17例腎上腺腫瘤患者實施經皮CT 導引氬氦冷凍消融術,其中3例因腫瘤較大,術後3月行第2次消融治療;4例因血供豐富消融前行動脈栓塞。8例嗜鉻細胞瘤患者術中行動脈連續測壓。結果所有患者操作均穫得成功,術中及術後無嚴重併髮癥。8例嗜鉻細胞瘤患者冷凍治療前後及複溫過程中血壓變化差異有統計學意義(P <0.05)。在隨訪3~24月中,消融區域 CT 掃描無增彊和/或 FDG PET-CT 無攝取。結論經皮 CT 導引氬氦冷凍消融術治療腎上腺腫瘤安全可靠,尤其可用于不適宜外科手術患者的治療。
목적:평개경피 CT 도인아양냉동소융술치료신상선종류적안전성급가행성。방법대17례신상선종류환자실시경피CT 도인아양냉동소융술,기중3례인종류교대,술후3월행제2차소융치료;4례인혈공봉부소융전행동맥전새。8례기락세포류환자술중행동맥련속측압。결과소유환자조작균획득성공,술중급술후무엄중병발증。8례기락세포류환자냉동치료전후급복온과정중혈압변화차이유통계학의의(P <0.05)。재수방3~24월중,소융구역 CT 소묘무증강화/혹 FDG PET-CT 무섭취。결론경피 CT 도인아양냉동소융술치료신상선종류안전가고,우기가용우불괄의외과수술환자적치료。
Objective To assess the safety and feasibility of CT-guided percutaneous argon-helium cryoablation in the treatment of adrenal tumors.Methods 1 7 patients with adrenal tumors were treated with CT-guided percutaneous argon-helium cryoablation. Three of these patients were retreated second cryoablation three months later due to the lager tumor diameters.Percutaneous tran-scatheter arterial embolization was performed in four patients because of rich blood supply before cryoablation.Continuous arterial blood pressure monitoring was performed in eight pheochromocytoma patients.Results Technical success was achieved in all pa-tients.There were no serious complications.Eight pheochromocytoma patients experienced a significant increase in systolic blood pressure and diastolic pressure when compared with the basic values (P <0.05).There were no enhancement on enhanced CT and/or up-take on FDG PET-CT in the ablated zones during the follow-up period (3-24months).Conclusion It is safety and efficacy of CT-guided percutaneous argon-helium cryoablation for adrenal tumor.It might be initial treatment of choice for the patients who were not suitable for resection.